Vision
We envision a future where understanding heart health is simple, non-invasive, and seamlessly integrated into everyday life.
KardioVis exists to bring people closer to their own cardiac health through technology that respects comfort, clarity, and human choice, supporting earlier awareness and more informed conversations between individuals and their physicians.
History
KardioVis S.r.l. was founded in August 2025 with one mission: to turn over a century of global expertise in technology, medtech and finance into life-saving impact.
Our goal: to detect heart failure early and with precision.
The journey began in 2023, when a founder developed an early prototype exploring the possibility of predicting heart failure risk up to four weeks before an acute event.
Initial experiments in his Bologna studio showed promising results. He shared it with a former mentee, now an international executive, who left his career driven by a deep desire to create something of high social impact, joining as co-founder. Two more soon followed — one with financial expertise, another with AI expertise, completing a team united to change cardiac care.
Management Team
Dynamic professional with expertise in project management, product development, and innovation.
Founder and President of ArtisMed S.r.l., where he led the creation of a wearable device for cardiac monitoring, coordinating engineers, designers, and medical consultants.
Strong background in business development, market analysis, and stakeholder management, with proven leadership in multidisciplinary teams.
Combines engineering and AI technical skills with entrepreneurial experience in the MedTech sector.
Accomplished executive with over 25+ years of international leadership in world-class companies such as Apple, Lamborghini, Ferrari Formula 1 and Bosch.
Throughout his career, he has successfully led multicultural teams across Europe and the United States, delivering breakthrough innovations in the automotive and high-tech sectors.
He combines deep expertise in system engineering, software processes, and product development with a proven ability to transform organizations and scale technology businesses.
Expert in building and leading multicultural teams, driving innovation, and delivering results in highly competitive global markets.
Biomedical engineer with 35+ years of international experience in R&D, product innovation, and clinical strategy at leading MedTech companies including Medtronic, Boston Scientific, Vitatron, and Sorin Biomedica.
Recognized expert in cardiac devices, implantable sensors, and monitoring systems, with 19 US patents and over 70 peer-reviewed publications.
Extensive experience in translating scientific innovation into market opportunities and shaping therapy adoption strategies worldwide.
Finance executive and CFA® charterholder with 20+ years of international experience in wealth management, corporate finance, and M&A advisory at leading institutions such as UBS, Banca Generali, and Fisher Investments Europe.
Proven track record in financial strategy, business planning, and valuation for high-growth companies.
Skilled in capital allocation, investor relations, and corporate governance, with strong ability to support startups through fundraising and scale-up phases.
Advisory Board
Professor Giuseppe Boriani Graduation in Medicine and Specialisation in Cardiology at the University of Bologna. PhD in Cardiovascular Physiopathology at the University of Milan. Full Professor of Cardiology at the University of Modena and Reggio Emilia and Chief of Cardiology, Modena University Hospital Fellow of ESC, of EHRA and of HFA.
Former Member of the Board of EHRA and Chair of the Health Economics Committee (2009-2013 and 2020-2024). Member of the Board of the Council on Cardio-Oncology of ESC (2018-2022 and 2024-) President (2016-2018) of the of AIAC (the Italian Society of Cardiac Pacing and Arrhythmology).
Scientific activity focused on clinical electrophysiology, pace-makers, ICDs, CRT, atrial fibrillation, heart failure, antiarrhythmic drugs, health economics and clinical cardiology.
Member of the Editorial board of the European Heart Journal and of the European Journal of Heart Failure Editor-in-Chief of EP europace.
Former Executive Apple Inc. and Sony Electronics.
20+ years extensive experience in development of Autonomous Systems and Consumer Electronics with a focus on realtime sensor data processing, video and graphics.
Experienced innovator with a strong background in technology development, intellectual property, and product strategy. As co-inventor on several international patents in advanced imaging and stabilization systems, he brings deep insight into how to build and protect differentiated, high-impact products.